Product
3HP plus DTG + 2NRTIs
1 clinical trial
2 indications
Indication
Respiratory Tract InfectionsIndication
HIV InfectionsClinical trial
Safety, Tolerability, and Drug-drug Interactions of Short-course Treatment of Latent Tuberculosis Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventative Therapy Among HIV-infected Patients Taking Dolutegravir-based Antiretroviral TreatmentStatus: Completed, Estimated PCD: 2022-12-07